This document discusses a case of a 31-year-old kidney transplant recipient who developed significant alopecia due to tacrolimus-based immunosuppression. The hair loss had a psychological impact, leading the patient to consider stopping treatment. Dermatological evaluation showed androgenetic alopecia and telogen effluvium. Switching from tacrolimus to cyclosporine A improved hair regrowth and well-being. A literature review found four similar cases linking alopecia to immunosuppressive therapy in organ transplant recipients. The study emphasizes the importance of awareness of hair disorders in transplant patients, suggesting regular dermatological assessments and potential adjustments in immunosuppressive regimens to improve patient quality of life and treatment adherence.
May 2026 in “Case Reports in Dermatology” This document discusses a case of a 31-year-old kidney transplant recipient who developed significant alopecia due to tacrolimus-based immunosuppression. The hair loss had a psychological impact, leading the patient to consider stopping treatment. A switch to cyclosporine A improved hair regrowth and well-being. A literature review identified four similar cases linking alopecia to immunosuppressive therapy in organ transplant recipients. The study emphasizes the importance of awareness among clinicians about hair disorders as side effects of immunosuppression, which can affect treatment adherence and quality of life. Regular dermatological assessments and personalized management, including adjusting immunosuppressive regimens, are recommended to mitigate these issues.
January 2025 in “Advances in Dermatology and Allergology” Hair disorders in organ transplant patients are often underestimated and need more attention and research.
17 citations
,
December 1997 in “Transplantation” Tacrolimus can cause hair loss in kidney transplant patients.
March 2025 in “JAAD International” Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.
